Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. AUROBINDO PHARMA CORAL LAB./
AUROBINDO PHARMA
 
P/E (TTM) x 14.5 23.0 63.1% View Chart
P/BV x 0.9 2.4 35.9% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 CORAL LAB.   AUROBINDO PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-23
AUROBINDO PHARMA
Mar-23
CORAL LAB./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs368715 51.5%   
Low Rs217397 54.6%   
Sales per share (Unadj.) Rs218.8424.2 51.6%  
Earnings per share (Unadj.) Rs18.132.9 54.9%  
Cash flow per share (Unadj.) Rs24.254.1 44.6%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs433.6458.1 94.7%  
Shares outstanding (eoy) m3.57585.94 0.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.3 102.1%   
Avg P/E ratio x16.216.9 95.9%  
P/CF ratio (eoy) x12.110.3 118.0%  
Price / Book Value ratio x0.71.2 55.6%  
Dividend payout %09.1 0.0%   
Avg Mkt Cap Rs m1,045325,753 0.3%   
No. of employees `000NANA-   
Total wages/salary Rs m11135,223 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m781248,554 0.3%  
Other income Rs m692,906 2.4%   
Total revenues Rs m850251,460 0.3%   
Gross profit Rs m3937,070 0.1%  
Depreciation Rs m2212,446 0.2%   
Interest Rs m31,405 0.2%   
Profit before tax Rs m8226,125 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m186,849 0.3%   
Profit after tax Rs m6419,277 0.3%  
Gross profit margin %4.914.9 33.0%  
Effective tax rate %21.626.2 82.6%   
Net profit margin %8.37.8 106.4%  
BALANCE SHEET DATA
Current assets Rs m1,235214,599 0.6%   
Current liabilities Rs m119114,938 0.1%   
Net working cap to sales %143.040.1 356.5%  
Current ratio x10.41.9 557.9%  
Inventory Days Days23121 1,119.9%  
Debtors Days Days1,09466 1,668.4%  
Net fixed assets Rs m508176,668 0.3%   
Share capital Rs m36586 6.1%   
"Free" reserves Rs m1,512267,813 0.6%   
Net worth Rs m1,548268,399 0.6%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m1,743392,125 0.4%  
Interest coverage x25.319.6 128.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.6 70.7%   
Return on assets %3.95.3 73.8%  
Return on equity %4.27.2 58.0%  
Return on capital %5.510.0 55.2%  
Exports to sales %92.133.7 273.4%   
Imports to sales %015.3 0.0%   
Exports (fob) Rs m71983,703 0.9%   
Imports (cif) Rs mNA38,060 0.0%   
Fx inflow Rs m71985,483 0.8%   
Fx outflow Rs m1341,447 0.0%   
Net fx Rs m70644,036 1.6%   
CASH FLOW
From Operations Rs m12723,868 0.5%  
From Investments Rs m-26-39,778 0.1%  
From Financial Activity Rs m-6418,144 -0.4%  
Net Cashflow Rs m362,298 1.6%  

Share Holding

Indian Promoters % 20.0 48.8 41.0%  
Foreign collaborators % 51.5 3.1 1,678.8%  
Indian inst/Mut Fund % 0.1 41.3 0.3%  
FIIs % 0.1 20.7 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 48.2 59.1%  
Shareholders   4,005 241,944 1.7%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on CORAL LAB. vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CORAL LAB. vs Aurobindo Pharma Share Price Performance

Period CORAL LAB. Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -4.03% 1.89% 1.18%
1-Month 2.28% 6.04% -0.75%
1-Year 64.47% 113.22% 61.82%
3-Year CAGR 4.67% 7.80% 18.16%
5-Year CAGR 3.11% 7.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the CORAL LAB. share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of CORAL LAB. hold a 71.5% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CORAL LAB. and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, CORAL LAB. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of CORAL LAB., and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.